Repletion of Ergothioneine in Patients With Kidney Failure
Stanford University
100 participants
Apr 1, 2025
INTERVENTIONAL
Conditions
Summary
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.
Eligibility
Inclusion Criteria1
- kidney failure receiving hemodialysis or peritoneal dialysis
Exclusion Criteria2
- blood transfusion within 90 days
- taking supplements which contain ergothioneine
Interventions
This is a 1-arm study in which participants will take ergothioneine daily with dose range of 5 mg to 25 mg daily. Blood levels of ergothioneine will be monitored while taking daily ergothioneine and after ergothioneine is stopped.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06487546